#Sweden #Gothenburg #revenue growth #Zinzino #Faun Pharma

Zinzino AB October 2026 Sales Report Highlights

In a recent update, Zinzino AB reported a modest revenue growth of 1% in October 2026 compared to the same month in the previous year. The total revenue reached SEK 325.1 million, slightly up from SEK 323.3 million in 2025. This increase reflects the company's ongoing strategy to enhance its market presence across various regions.

Overview of Zinzino’s Financial Performance

During this period, Zinzino's subsidiary, Faun Pharma, saw an impressive growth in external sales, soaring by 33%, which translated into SEK 3.6 million, up from SEK 2.7 million. This performance is noteworthy as it contributes to the overall health of the Zinzino Group, which recorded total revenues of SEK 328.7 million, a rise from SEK 326.0 million year-on-year.

The accumulated revenue from January to October 2026 stood at SEK 3,128.0 million, marking a significant increase of 19% compared to SEK 2,628.2 million during the same period in 2025. This sharp rise emphasizes Zinzino's resilience and adaptability in the highly competitive market.

Regional Performance Analysis

A closer examination of the revenues shows varied performances across different regions:

• - The Nordics: Revenue was SEK 29.4 million, a drop from SEK 36.9 million, indicating a 20% decline. Year-to-date revenue slightly decreased by 2% compared to the previous year.
• - Central Europe: Here, the revenue remained relatively steady at SEK 101.6 million, a 1% increase over the previous year. This region has shown a robust year-to-date growth of 26%.
• - East Europe: This area saw revenues of SEK 26.3 million, reflecting a 24% decline and a 13% drop in year-to-date figures.
• - South West Europe: Generating SEK 49.6 million, the revenue decreased by 13% with a 10% rise in year-to-date comparisons.
• - The Baltics: Experienced a sharp revenue drop to SEK 8.7 million, down 33% from the previous year.
• - North America: This region was a standout performer, with revenues reaching SEK 72.2 million, a striking 46% increase year-to-date.
• - South America: The revenue rose to SEK 2.8 million, marking a considerable 87% growth compared to previous years.
• - Asia-Pacific: Here, the revenues improved by 17%, totaling SEK 32.3 million.
• - Africa: The revenue remained stable at SEK 2.2 million, showing a slight decrease of 4% year-on-year.

Zinzino's ability to navigate these diverse market conditions showcases its strategic focus and marketing effectiveness, especially in regions like North America and various Asian markets, which are proving increasingly vital for its growth trajectory.

Future Outlook

As Zinzino looks forward, the company’s leadership highlights a commitment to expanding its footprint and trying innovative products while maintaining its foundational strategies. The ongoing analysis of market trends and customer needs will be critical in sustaining growth. Zinzino continues to engage investors and stakeholders through regular updates, emphasizing transparency in its operations and financial performance.

This preliminary report sets a commendable stage for Zinzino’s future as it continues to adapt and thrive in the dynamic health and wellness market, building on its strengths and addressing challenges proactively.

For further inquiries, stakeholders can contact:

• - Dag Bergheim Pettersen, CEO Zinzino

Phone: +47 (0) 932 25 700
Email: [email protected]

• - Fredrik Nielsen, CFO Zinzino

Phone: +46 707 900 174
Email: [email protected]

This financial update not only reflects Zinzino's past performance but also sets the tone for future opportunities as the company continues to innovate and expand its reach across global markets.